98996-29-3 Usage
Ethyl ester derivative
1-Methyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid The compound is derived from 1-methyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid by attaching an ethyl ester group, which modifies its properties and potential applications.
Heterocyclic compound
The presence of nitrogen in the ring structure This refers to the compound's structure, which contains a ring of atoms including a nitrogen atom, making it a heterocyclic compound.
Potential pharmaceutical applications
Unique structural properties and pharmacological activities The compound has potential uses in the pharmaceutical industry due to its specific structure and possible effects on biological systems.
Yellowish crystalline powder
Physical appearance The compound's appearance is a yellowish crystalline powder, which may affect how it is handled and used in various applications.
Molecular weight
195.21 g/mol This is the mass of one mole of the compound, which can be used to calculate the mass of a given amount of the substance.
Synthesis of various drugs and pharmaceuticals
Use in drug production The compound is commonly used as a starting material or intermediate in the synthesis of different drugs and pharmaceuticals, taking advantage of its unique properties.
Research and development laboratories
Utilization in chemical synthesis and medicinal chemistry studies The compound is also used in research settings to study its properties, potential applications, and to develop new drugs and pharmaceuticals based on its structure.
Check Digit Verification of cas no
The CAS Registry Mumber 98996-29-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,8,9,9 and 6 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 98996-29:
(7*9)+(6*8)+(5*9)+(4*9)+(3*6)+(2*2)+(1*9)=223
223 % 10 = 3
So 98996-29-3 is a valid CAS Registry Number.
98996-29-3Relevant articles and documents
Synthesis, Chemistry, and Antineoplastic Activity of α-Halopyridinium Salts: Potential Pyridone Prodrugs of Acylated Vinylogous Carbinolamine Tumor Inhibitors
Anderson, Wayne K.,Dean, Dennis C.,Endo, Toshiyasu
, p. 1667 - 1675 (2007/10/02)
A series of 4- and 5-methyl>-1H-pyrrolizin-5-yl>-2-halopyridinium iodides were synthesized.The rates of hydrolysis of the α-halopyridinium salts to the corresponding pyridones, and the reactivities of the carbamate moieties were studied as a function of pH, buffer composition, and ionic strength.The 4- and 5-pyrrolizinyl-2-halopyridinium iodides and the corresponding pyridones were evaluated against P388 lymphocytic leukemia in vivo.The α-fluoropyridinium compounds were active but the α-chloro compounds were not.This activity was correlated with the rates of hydrolysis of the α-halopyridinium compounds to the active pyridone.Compounds that were active in the P388 screen were evaluated in L1210 leukemia, M5076 carcinoma, and MX-1 mammary xenograft assays in mice.
